跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,660 条关于
“FGFR inhibitors”
全部
15,660
临床试验
7,896
药物
3,378
机构
8
资讯
4,378
去年
FDA-Approved FGFR Inhibitors Show Promise for Pediatric Brain Tumors in Preclinical Studies
去年
TransThera's Tinengotinib Shows Promise Against FGFR-Resistant Cholangiocarcinoma in Annals of Oncology Study
去年
LOXO-435 Shows Promise as Selective FGFR3 Inhibitor in Metastatic Urothelial Cancer Trial
去年
Tyra Biosciences' FGFR3 Inhibitor TYRA-300 Shows Promise in Urothelial Cancer
去年
TYRA-300: Novel FGFR3-Selective Inhibitor Shows Promise in Urothelial Cancer and Achondroplasia
11年前
Tyra Biosciences Advances FGFR Inhibitor Pipeline with Multiple Clinical Trials
7年前
FGFR1 Overexpression Identified as a Key Resistance Mechanism to CDK4/6 Inhibitors in ER+ Breast Cancer
前天
Elevar Submits EMA Marketing Authorization Application for Lirafugratinib in FGFR2-Fusion Cholangiocarcinoma
2个月前
FGFR Inhibitor Cancer Drugs Linked to Dry Eye and Corneal Damage in FAERS Analysis
去年
TYRA-300 Shows Promise in Treating Metastatic Bladder Cancer with FGFR3 Alterations
第 1 页,共 438 页
上一页
下一页